ESC Congress 2019 Conference Review, reviewed by Prof Richmond Jeremy

In this review:

2019 ESC Guidelines
š Chronic coronary syndromes
š Diabetes, prediabetes and CV diseases, in collaboration with EASD
š Dyslipidaemias
š The optimal diagnostic approach to cardiotoxicity
Clinical genetics and precision medicine
š Functional annotation of CV disease gene variants of uncertain significance
ODYSSEY trial and clinical outcomes
š Insights and lessons from ODYSSEY: which patients benefit most?
š Implications of new CV risk reduction indication of PCSK9 inhibitors
Valvular heart disease
š Investigating and intervening in low gradient aortic stenosis
š Managing mitral regurgitation and reduced LV function

Please login below to download this issue (PDF)